Fueled by an aging population, growing healthcare expenditures and rapidly advancing technology, our Emerging Life Sciences Fund (currently closed) offers investors the opportunity to invest in a professionally managed niche investment strategy.

The Fund’s focus is on biotechnology, pharmaceutical, medical technology and medical service opportunities within the healthcare and life sciences sectors. The Fund seeks to recreate an experience akin to successful venture capital investing through selective long-term investments in under-followed companies that are less than $500M in market capitalization.

Back to Alternative Investments